FDA Inspection 1035733 — ABX Advanced Biochemical Compounds Biomedizinische Forschungsreagenzien GmbH

ABX Advanced Biochemical Compounds Biomedizinische Forschungsreagenzien GmbH — FEI 3004849998

The FDA completed an inspection of ABX Advanced Biochemical Compounds Biomedizinische Forschungsreagenzien GmbH on September 15, 2017 in Radeberg. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 15, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Radeberg (Germany)